Gestational diabetes mellitus (Class A): A human teratogen?

American Journal of Medical Genetics

Volumn 83, Issue 5, 1999, Pages 402-408

  Kousseff, Boris G ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Caudal deficiency; Diabetes mellitus; Diabetic embryopathy; Malformations; Pregnancy; Teratogen

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EMBRYOPATHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORGANOGENESIS; PATHOGENESIS; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; TERATOGENESIS;

ABNORMALITIES; ADOLESCENT; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES, GESTATIONAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LIMB DEFORMITIES, CONGENITAL; MALE; PHENOTYPE; PREGNANCY;

ANIMALIA;

EID: 0033597189     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990423)83:5<402::AID-AJMG12>3.0.CO;2-F     Document Type: Article

References (59)

1. Baker L, Piddington R. 1993. Diabetic embryopathy: A selective review of recent trends. J Diab Complications 7:204-212.
2. Baker L, Piddington R, Goldman AS, Egler J. 1986. Diabetic embryopathy: Mechanism involves myo-inositol and arachidonic acid. Pediatr Res 20:326A.
3. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: A population-based case-control study. Pediatrics 85:1-9.
4. Berkus MD, Xenakis EMJ, Langer O. 1992. Glucose tolerance test periodicity as a descriptor of glucose tolerance abnormality. Obstet Gynecol 79:931-935.
5. Buck D, Greene AE, Coriell LL, Mulivor RA. 1980. Fibroblasts have reduced replicative life span in DM juvenile onset diabetes. Cytogenet Cell Genet 28:213-216.
6. Cederberg J, Eriksson UJ. 1997. Decreased catalase activity in malformation-prone embryos of diabetic rats. Teratology 56:350-357.
7. Chung CS, Myrianthopoulos NC. 1975. Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations. Birth Defects 11(10):23-37.
8. Dornhorst M, Davies V, Anyaoku V, Hampton SM, Elkeles RS, Beard RW, Johnston DG. 1991. Abnormalities in fasting circulating proinsulin concentration in mild gestational diabetes. Clin Endocrinol 34:211-213.
9. Duncan JM. 1882. On puerperal diabetes. Trans Obstet Soc Lond 24:256-285.
10. Ely JTA. 1981. Hyperglycemia and major congenital anomalies. N Engl J Med 305:833.
11. Eriksson UJ, Borg LAH, Cagliero E, Forsberg H, Styrud J. 1992. Teratogenesis in diabetic pregnancy: Metabolism of oxidative substrates and generation of free oxygen radicals. Teratology 45:510.
12. Eriksson UJ, Borg LAH. 1993. Diabetes and embryonic malformations: Role of substrate-induced free-oxygen radical production of dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419.
13. Farquhar JW. 1959. The child of the diabetic woman. Arch Dis Child 34: 76-96.
14. Freinkel N. 1980. Of pregnancy and progeny. Diabetes 29:1023-1035.
15. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. 1983. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 6:219-223.
16. Gabbe SG. 1977. Congenital malformations in infants of diabetic mothers. Obstet Gynecol Surv 32:125-131.
17. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82:8227-8231.
18. 2 in mouse embryo culture. Pediatr Res 25(4):198A.
19. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Erikkson UJ, Groner Y. 1995. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173: 1036-1041.
20. Hawthorne G, Snodgrass A, Turnbridge M. 1994. Outcome of diabetic pregnancy and glucose intolerance in pregnancy: An audit of fetal loss in Newcastle General Hospital 1977-1990. Diabetes Res Clin Pract 25: 183-190.
21. Hod M, Merlob P, Friedman S, Schoenfelf A, Ovadia J. 1991. Gestational diabetes mellitus, a survey of perinatal complications in the 1980s. Diabetes 40(suppl 2):74-78.
22. Horton WE Jr, Sadler TW. 1983. Effects of maternal diabetes on early embryogenesis: Alterations in morphogenesis produced by the ketone body, β-hydroxybutyrate. Diabetes 32:610-616.
23. Jankowski MA, Uriu-Hare JY, Rucker RB, Keen CL. 1994. Embryonic cell death patterns are different in embryos from zinc (Zn) deficient dams compared to embryos from copper (Cu) deficient, and diabetic dams. Teratology 49:89.
24. Janssen PA, Rothman I, Schwartz SM. 1996. Congenital malformations in newborns of women with established and gestational diabetes in Washington State. Paediatr Perinat Epidemiol 10:469-476.
25. Karlsson K, Kjellmer I. 1972. The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynecol 112:213-220.
26. Kennedy L, Baynes JW. 1984. Non-enzymatic glycosylation and the chronic complications of diabetes: An overview. Diabetologia 26:93-98.
27. Khoury MJ, Becerra JE, Cordero JF, Erickson JD. 1989. Clinical-epidemiologic assessment of patterns of birth defects associated with human teratogens: Application to diabetic embryopathy. Pediatrics 84: 658-665.
28. Kitzmiller JL, Cloherty JP, Younger MD, Tabatabaii A, Rothchild SB, Sosenko I, Epstein MF, Singh S, Neff RK. 1978. Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131:560-580.
29. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. 1991. Preconception care of diabetes. JAMA 265:731-736.
30. Kousseff BG. 1992. Hypothesis: Jadassohn nevus phakomatosis: A paracrinopathy with variable phenotype. Am J Med Genet 43:651-661.
31. Kousseff BG. 1990. The phakomatoses as paracrine growth disorders (paracrinopathies). Clin Genet 37:97-105.
32. Kousseff BG, Villaveces C, Martinez CR. 1991. Unique brain anomalies in an infant of a diabetic mother. Acta Paediatr Scand 80:110-115.
33. Kucera J. 1971. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7:61-64.
34. Martinez-Frías ML, Bermejo E, Rodriques-Pinilla E, Prieto L, Frías JL. 1998. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 78:140-145.
35. McCarter RJ, Kessler II, Comstock GW. 1987. Is diabetes mellitus a teratogen or a coteratogen? Am J Epidemiol 125:195-205.
36. Mills JL. 1986. Malformations in infants of diabetic mothers. In: Sever JL, Brent RL, editors. Teratogen update: Environmentally induced birth defect risks. New York: Alan R. Liss Inc. p 165-376.
37. Mills JL, Baker L, Goldman AS. 1978. Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment. Diabetes 28:292-293.
38. Mølsted-Pedersen L, Pedersen JF. 1985. Congenital malformations in diabetic pregnancies. Acta Paediatr Scand 320:79-84.
39. Mølsted-Pedersen L, Tygstrup I, Pedersen J. 1964. Congenital malformations in newborn infants of diabetic women. Lancet 1:1124-1126.
40. Navarette VN, Rojas CE, Alger CR, Paniagua HE. 1970. Subsequent diabetes in mothers delivered of a malformed infant. Lancet 2:993-995.
41. Neufeld ND, Corbo L, Brunnerman S. 1985. Detection of gestational diabetes in the first trimester: Abnormalities in cell membrane, structure and function. Pediatr Res 19:317A.
42. Opitz JM. 1993. Blastogenesis and the "primary field" in human development. Birth Defects 29:3-37.
43. Reece EA, Hobbins JC. 1986. Diabetic embryopathy: Pathogenesis, prenatal diagnosis and prevention. Obstet Gynecol Surv 41:325-335.
44. Reece EA, Homko CJ, Ying-King WU. 1996. Multifactorial basis of the syndrome of diabetic embryopathy. Teratology 54:171-182.
45. Reid RA. 1970. Diabetes and congenital abnormalities. Lancet 1:1030-1031.
46. Sadler TW, Denno KM, Hunter ES III. 1993. Effects of altered maternal metabolism during gastrulation and neurulation stages of embryogenesis. Maternal nutrition and pregnancy outcome. Ann NY Acad Sci 678:48-61.
47. Sadler LS, Robinson LK, Msall ME. 1995. Diabetic embryopathy: Possible pathogenesis. Am J Med Genet 55:363-366.
48. Sadler TW, Hunter ES III, Wynn RE, Phillips LS. 1989. Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 38:70-74.
49. Sadler TW, Phillips LS, Balkan W, Goldstein S. 1986. Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 35:861-865.
50. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. 1997. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 177:1165-1171.
51. Shaw GM, Velie EM, Schaffer D. 1996. Risk of neural tube defect-affected pregnancies among obese women. JAMA 275:1093-1096.
52. Sivan E, Lee YC, Wu YK, Reece EA. 1997. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 56:343-349.
53. Super DM, Edelberg SC, Philipson EH, Hertz RH, Kalahan SC. 1991. Diagnosis of gestational diabetes in early pregnancy. Diabet Care 14: 288-294.
54. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. 1986. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 315:989-992.
55. Villee CA. 1984. Birth defects and glycolysis. N Engl J Med 310:254-255.
56. Waller DK, Mills JL, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Rhoads GC. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170:541-548.
57. Watkins MA, Scanlon KS, Mulinare J, Khoury MJ. 1994. Is maternal obesity a risk factor for anencephaly and spina bifida? Teratology 49:93.
58. White P. 1978. Classification of obstetric diabetes. Am J Obstet Gynecol 130:228-230.
59. Wilson GN. 1985. Altered developmental sequences in diabetic embryopathy. N Engl J Med 312:1519-1520.